Evidence map›Paper›PMID 34204139›Full record

ArticleInternational journal of molecular sciences2021

Activation of the Integrated Stress Response and ER Stress Protect from Fluorizoline-Induced Apoptosis in HEK293T and U2OS Cell Lines.

José Saura-Esteller, Ismael Sánchez-Vera, Sonia Núñez-Vázquez, Ana M Cosialls, Pau Gama-Pérez, Gauri Bhosale, Lorena Mendive-Tapia, Rodolfo Lavilla, Gabriel Pons, Pablo M Garcia-Roves and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Identification of Neferine as a DOR Agonist Activating GInternational journal of molecular sciences · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

José Saura-EstellerDepartament de Ciències Fisiològiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona-IDIBELL (Institut d'Investigació Biomèdica de Bellvitge), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.ORCID 0000-0001-6924-7798
Ismael Sánchez-VeraDepartament de Ciències Fisiològiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona-IDIBELL (Institut d'Investigació Biomèdica de Bellvitge), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.ORCID 0000-0001-6518-3117
Sonia Núñez-VázquezDepartament de Ciències Fisiològiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona-IDIBELL (Institut d'Investigació Biomèdica de Bellvitge), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.ORCID 0000-0002-3419-9332
Ana M CosiallsDepartament de Ciències Fisiològiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona-IDIBELL (Institut d'Investigació Biomèdica de Bellvitge), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
Pau Gama-PérezDepartament de Ciències Fisiològiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona-IDIBELL (Institut d'Investigació Biomèdica de Bellvitge), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.ORCID 0000-0003-4342-0286
Gauri BhosaleDepartment of Cell and Developmental Biology, University College London, London WC1E6BT, UK.
Lorena Mendive-TapiaLaboratory of Medical Chemistry, Faculty of Pharmacy and Food Sciences and Institute of Biomedicine (IBUB), University of Barcelona, 08028 Barcelona, Spain.
Rodolfo LavillaLaboratory of Medical Chemistry, Faculty of Pharmacy and Food Sciences and Institute of Biomedicine (IBUB), University of Barcelona, 08028 Barcelona, Spain.ORCID 0000-0002-5006-9917
Gabriel PonsDepartament de Ciències Fisiològiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona-IDIBELL (Institut d'Investigació Biomèdica de Bellvitge), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
Pablo M Garcia-RovesDepartament de Ciències Fisiològiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona-IDIBELL (Institut d'Investigació Biomèdica de Bellvitge), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
Michael R DuchenDepartment of Cell and Developmental Biology, University College London, London WC1E6BT, UK.
Daniel Iglesias-SerretDepartament de Ciències Fisiològiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona-IDIBELL (Institut d'Investigació Biomèdica de Bellvitge), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
Joan GilDepartament de Ciències Fisiològiques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona-IDIBELL (Institut d'Investigació Biomèdica de Bellvitge), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.ORCID 0000-0002-3686-3903
Institut d'Investigació Biomédica de Bellvitge · ESUniversitat de Barcelona · ESUniversity College London · GBUniversitat de Vic - Universitat Central de Catalunya · ES

Funding

Agencia Estatal de Investigacion SAF2017-83178-RAgencia Estatal de Investigación PID2019-107991RB-I00Government of Catalonia Suport Grups de Recerca AGAUR 2017-SGR-204Instituto de Salud Carlos III (ISCIII) PI15/00701
6 · The paper itself

Abstract

The prohibitin (PHB)-binding compound fluorizoline as well as PHB-downregulation activate the integrated stress response (ISR) in HEK293T and U2OS human cell lines. This activation is denoted by phosphorylation of eIF2α and increases in ATF4, ATF3, and CHOP protein levels. The blockage of the activation of the ISR by overexpression of GRP78, as well as an increase in IRE1 activity, indicate the presence of ER stress after fluorizoline treatment. The inhibition of the ER stress response in HEK293T and U2OS led to increased sensitivity to fluorizoline-induced apoptosis, indicating a pro-survival role of this pathway after fluorizoline treatment in these cell lines. Fluorizoline induced an increase in calcium concentration in the cytosol and the mitochondria. Finally, two different calcium chelators reduced fluorizoline-induced apoptosis in U2OS cells. Thus, we have found that fluorizoline causes increased ER stress and activation of the integrated stress response, which in HEK293T and U2OS cells are protective against fluorizoline-induced apoptosis.

Indexed as

ApoptosisCalciumCell Line, TumorCell RespirationDown-RegulationEndoplasmic Reticulum Chaperone BiPEndoplasmic Reticulum StressHEK293 CellsHomeostasisHumansMitochondriaProhibitinsReactive Oxygen SpeciesRepressor ProteinsSignal TransductionThiazolesCalciumEndoplasmic Reticulum Chaperone BiPHSPA5 protein, humanPHB protein, humanProhibitinsReactive Oxygen SpeciesRepressor ProteinsThiazolesapoptosisER stressfluorizolineISRprohibitin

Identifiers

PMID34204139
PMCPMC8201103
OpenAlexW3170596676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.